Surgalign Holdings, Inc.
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -18.72% | -5.76% | -1.79% | -16.96% | -11.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -18.72% | -5.76% | -1.79% | -16.96% | -11.53% |
| Cost of Revenue | -2.68% | 7.46% | -20.43% | -18.13% | 5.06% |
| Gross Profit | -25.31% | -15.03% | 6.56% | -16.53% | -16.92% |
| SG&A Expenses | -16.55% | -10.99% | -13.46% | -4.90% | -3.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 77.16% | -- | -- | -- |
| Total Operating Expenses | -16.48% | -1.87% | -10.96% | -4.42% | 2.93% |
| Operating Income | 13.43% | -4.48% | 22.55% | -25.06% | -32.32% |
| Income Before Tax | 2,163.49% | 54.40% | -2.47% | 47.00% | 101.26% |
| Income Tax Expenses | -17.90% | -1,231.36% | 102.91% | 13.58% | -26.03% |
| Earnings from Continuing Operations | 15,251.85% | 55.97% | -19.12% | 46.54% | 100.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15,251.85% | 13.78% | -24.37% | 64.87% | 100.18% |
| EBIT | 13.43% | -4.48% | 22.55% | -25.06% | -32.32% |
| EBITDA | 13.52% | -6.05% | 22.59% | -26.81% | -33.48% |
| EPS Basic | 10,825.53% | 41.28% | 14.91% | 79.85% | 100.10% |
| Normalized Basic EPS | 9.57% | -107.39% | -10.87% | 60.84% | 71.24% |
| EPS Diluted | -728.26% | 41.31% | 14.85% | 79.77% | 100.10% |
| Normalized Diluted EPS | 43.50% | -107.39% | -10.87% | 60.84% | 72.10% |
| Average Basic Shares Outstanding | 40.79% | 46.84% | 46.17% | 74.36% | 75.32% |
| Average Diluted Shares Outstanding | 125.36% | 46.84% | 46.17% | 74.36% | 80.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |